Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 7

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 7
---
OTING

This proxy statement contains information about the Special Meeting of Stockholders of Aadi Bioscience, Inc., to be held online on [●], 2025at
[●] Pacific Time. The Special Meeting (together with any adjournment or postponement thereof, the “Special Meeting”) will be a virtual meeting. You will be able to attend and participate in the Special Meeting online by visiting
www.virtualshareholdermeeting.com/AADI2025SM, where you will be able to listen to the Special Meeting live, submit questions and vote. Further information about how to attend the Special Meeting online is included in this proxy statement.

After careful consideration, Aadi’s board of directors has unanimously determined that the Divestiture Agreement and the transactions contemplated
thereby, completion of the PIPE Financing and the Equity Plan Increase are advisable and in the best interests of Aadi and its stockholders. Aadi’s board of directors unanimously recommends that Aadi stockholders vote: (1) “FOR” the Divestiture Proposal, (2) “FOR” the PIPE Financing Proposal, (3) “FOR” the Equity Plan Increase Proposal, (4) “FOR” the Non-BindingAdvisory Vote onGolden Parachutes Proposal and (5) “FOR” the Adjournment Proposal. Aadi’s board of directors is using this proxy statement to solicit proxies for use at the Special Meeting. In this proxy statement, unless expressly stated otherwise
or the context otherwise requires, references to “Aadi,” “the Company,” “we,” “us,” “our” and similar terms refer to Aadi Bioscience, Inc. References to our website are inactive textual references
only and the contents of our website are not incorporated by reference into this proxy statement.

All properly submitted proxies will be voted in
accordance with the instructions contained in those proxies. If no instructions are specified, the shares represented by the proxies will be voted in accordance with the recommendation of Aadi’s board of directors with respect to each of the
matters set forth in this proxy statement. Your proxy is revocable in accordance with the procedures set forth in this proxy statement.

For additional
questions about the proposals, assistance in submitting proxies or voting shares of Aadi’s common stock, or to request additional copies of the proxy statement or the enclosed proxy card, please contact our proxy solicitor at:

SODALI & CO

430 Park Avenue,
14th Floor

New York, NY 10022